News
-
April 24, 2012
Tucson institute plays critical cancer role
Re: the April 19 article “Vast study advances breast cancer fight.” -
April 23, 2012
ACRO Testifies Before FDA on Clinical Trial Modernization
WASHINGTON–(BUSINESS WIRE)– The Association of Clinical Research Organizations (ACRO) today provided the FDA with a number of suggestions to improve the drug development process, highlighted by a call to appoint a Chief Innovation Officer within the agency. ACRO’s recommendations were included in testimony presented by Executive Director Doug Peddicord, Ph.D., at a public hearing titled... -
April 20, 2012
C-Path Initiative’s Work on Personalized Medicine Starts to Get Results
The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to advance personalized medicine, is advancing quickly and is bearing results, reports The Arizona Star. -
April 17, 2012
C-Path Looks to Speed Gene Based Therapies
Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic blueprint, and get it in about eight hours for about $100. That’s stunning news, considering the same test took up to a year and $100 million a decade ago, and... - April 17, 2012